To further evaluate antigen-specific CD8+ T cell responses, we used the TC-1 model, which allowed longer tumor monitoring and assessment of E7/H2Db tetramer+CD8+ T cells (Figures 2, 5, and 6). Here, CD8A is linked to neoplasm.